Clinical Trials Browser

Phase 2 × Myasthenia Gravis × rhoA GTP-Binding Protein × Clear all

NCT05218096 2025-01-09

Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis

Phase 2 Terminated

70 enrolled 14 charts

Myasthenia Gravis